Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

TARA.US Logo

TARA.US - Current Price

$5.24

Company Information

▼
Company Name
Protara Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US74365U1079
CIK: 0001359931
CUSIP: 04300J107
Currency: USD
Full Time Employees: 28
Phone: 646 844 0337
Website: https://www.protaratx.com
Fiscal Year End: December
IPO Date: Oct 22, 2014
Description:

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.

Address:

345 Park Avenue South, New York, NY, United States, 10010

Directors & Officers

▼
Name Title Year Born
Mr. Jesse Shefferman Co-founder, CEO, President & Director 1972
Dr. Jacqueline Zummo M.B.A., M.P.H., Ph.D. Co-Founder & Chief Scientific Operations Officer 1981
Mr. Patrick Fabbio M.B.A. Chief Financial Officer 1968
Ms. Hannah Fry VP, Principal Accounting Officer & Controller 1991
Ms. Justine O'Malley Senior Vice President of Investor Relations & Corporate Affairs NA
Ms. Mary J. Grendell J.D. General Counsel & Corporate Secretary NA
Dr. Shane Williams Ph.D. Chief People Officer NA
Dr. Leonardo Viana Nicacio M.D. Chief Medical Officer 1978
Mr. William Conkling Chief Commercial Officer 1972

Shares Statistics

▼
Shares Outstanding: 53.59M
Shares Float: 37.89M
% Insiders: 203.80%
% Institutions: 5,219.20%
Short % Float: 4.18%

Valuation Metrics

▼
Enterprise Value: $151.78M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $280.80M
EBITDA: $-59.43M
Book Value: $3.43
Earnings/Share: $-1.39
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -31.30%
ROE (TTM): -49.42%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Sep 30, 2025 -0.31 -0.38 N/A 1,788.08%
Jun 30, 2025 -0.35 -0.40 N/A 1,250.00%
Mar 31, 2025 -0.29 -0.48 N/A 3,926.70%
Dec 31, 2024 -0.43 -0.57 N/A 2,389.38%
Sep 30, 2024 -0.50 -0.52 N/A 338.46%
Jun 30, 2024 -0.45 -0.80 N/A 4,375.00%
Mar 31, 2024 -0.97 -0.92 N/A -543.48%
Dec 31, 2023 -0.90 -0.92 N/A 217.39%
Sep 30, 2023 -0.87 -0.98 N/A 1,122.45%
Jun 30, 2023 -1.00 -0.87 N/A -1,494.25%
Mar 31, 2023 -0.80 -0.88 N/A 909.09%
Dec 31, 2022 -1.55 -0.75 N/A -10,666.67%
Sep 30, 2022 -0.68 -0.76 N/A 1,052.63%
Jun 30, 2022 -0.80 -0.94 N/A 1,489.36%
Mar 31, 2022 -0.96 -0.90 N/A -666.67%
Dec 31, 2021 -0.91 -0.94 N/A 319.15%
Sep 30, 2021 -0.96 -1.01 N/A 495.05%
Jun 30, 2021 -1.14 -1.05 N/A -857.14%
Mar 31, 2021 -1.20 -0.73 N/A -6,438.36%
Dec 31, 2020 -0.44 -0.54 N/A 1,851.85%
Sep 30, 2020 -1.26 -0.62 N/A -10,322.58%
Jun 30, 2020 -1.22 -0.46 N/A -16,521.74%
Mar 31, 2020 -1.81 -0.41 N/A -34,146.34%
Dec 31, 2019 -2.55 -0.71 N/A -25,915.49%
Sep 30, 2019 -3.20 -3.60 N/A 1,111.11%
Jun 30, 2019 -10.80 -6.80 N/A -5,882.35%
Mar 31, 2019 -13.60 -9.00 N/A -5,111.11%
Dec 31, 2018 -10.80 -10.20 N/A -588.24%
Sep 30, 2018 -10.00 -12.00 N/A 1,666.67%
Jun 30, 2018 -11.20 -14.20 N/A 2,112.68%
Mar 31, 2018 -13.60 -13.84 N/A 173.41%
Dec 31, 2017 -12.40 -16.80 N/A 2,619.05%
Sep 30, 2017 -28.00 -15.53 N/A -8,029.62%
Jun 30, 2017 -13.20 -17.20 N/A 2,325.58%
Mar 31, 2017 -15.60 -16.70 N/A 658.68%
Dec 31, 2016 -16.80 -18.30 N/A 819.67%
Sep 30, 2016 -17.20 -18.80 N/A 851.06%
Jun 30, 2016 -19.20 -17.04 N/A -1,267.61%
Mar 31, 2016 -16.00 -16.32 N/A 196.08%
Dec 31, 2015 -15.60 -13.70 N/A -1,386.86%
Sep 30, 2015 -13.20 -13.20 N/A 0.00%
Jun 30, 2015 -12.40 -11.87 N/A -446.50%
Mar 31, 2015 -11.20 -12.30 N/A 894.31%
Dec 31, 2014 -9.44 -10.53 N/A 1,035.14%
Sep 30, 2014 -1.24K -12.60 N/A -975,079.37%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $162.80M $N/A $181.45M $14.32M $167.13M
2023-12-31 $39.59M $N/A $78.95M $10.63M $68.32M
2022-12-31 $24.13M $N/A $113.29M $11.21M $102.08M
2021-12-31 $35.72M $N/A $172.60M $10.68M $161.91M
2020-12-31 $168.60M $N/A $203.16M $3.91M $199.24M
2019-12-31 $6.18M $N/A $6.98M $583.00K $6.39M
2018-12-31 $19.37M $N/A $23.52M $3.08M $20.44M
2017-12-31 $21.17M $N/A $43.98M $9.24M $34.74M
2016-12-31 $36.39M $N/A $43.52M $5.08M $38.44M
2015-12-31 $40.03M $N/A $67.54M $4.13M $63.41M
2014-12-31 $68.84M $N/A $84.80M $2.34M $82.46M
2013-12-31 $2.83M $N/A $5.66M $9.77M $-4.11M
2012-12-31 $2.41M $N/A $7.78M $4.15M $3.63M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 26, 2025 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist